Accueil › BPCO › Texas › Dallas
Essais cliniques pour BPCO à Dallas, TX
12 études pour BPCO recherchent des participants dans et autour de Dallas (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Recrutement en coursPhase 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Recrutement en coursPhase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Recrutement en cours
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Recrutement en coursPhase 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Recrutement en coursPhase 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Recrutement en coursPhase 2/3
- Alina Clinical Trials, LLC., Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Recrutement en coursPhase 3
- Research Site, Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Recrutement en coursPhase 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
Recrutement en coursÉtude observationnelle
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Recrutement en coursPhase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Recrutement en coursÉtude observationnelle
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Recrutement en coursPhase 3
- GSK Investigational Site, Dallas
Essais pour BPCO dans d'autres villes
- Philadelphia, PA23 études
- Miami, FL18 études
- Birmingham, AL17 études
- Boston, MA17 études
- Orlando, FL15 études
- Houston, TX15 études
- Baltimore, MD14 études
- Chicago, IL14 études
- Pittsburgh, PA12 études
- New York City, NY11 études
- Ann Arbor, MI10 études
- Detroit, MI9 études
Autres études à Dallas
- Cancer du sein55 études
- Cancer du poumon non à petites cellules52 études
- Insuffisance cardiaque42 études
- Cancer métastatique42 études
- Cancer (tous types)37 études
- Cancer de la prostate36 études
- Cancer colorectal33 études
- Obésité31 études
- Cancer de l'ovaire28 études
- Cancer du poumon27 études
- Cancer de la vessie27 études
- Cancer de l'endomètre24 études
Source : ClinicalTrials.gov, données récupérées le 2 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.